1. Home
  2. EBF vs ALLO Comparison

EBF vs ALLO Comparison

Compare EBF & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBF
  • ALLO
  • Stock Information
  • Founded
  • EBF 1909
  • ALLO 2017
  • Country
  • EBF United States
  • ALLO United States
  • Employees
  • EBF N/A
  • ALLO N/A
  • Industry
  • EBF Office Equipment/Supplies/Services
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EBF Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • EBF Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • EBF 542.4M
  • ALLO 438.2M
  • IPO Year
  • EBF N/A
  • ALLO 2018
  • Fundamental
  • Price
  • EBF $20.90
  • ALLO $1.90
  • Analyst Decision
  • EBF
  • ALLO Strong Buy
  • Analyst Count
  • EBF 0
  • ALLO 10
  • Target Price
  • EBF N/A
  • ALLO $10.06
  • AVG Volume (30 Days)
  • EBF 128.7K
  • ALLO 3.0M
  • Earning Date
  • EBF 12-23-2024
  • ALLO 03-13-2025
  • Dividend Yield
  • EBF 16.63%
  • ALLO N/A
  • EPS Growth
  • EBF N/A
  • ALLO N/A
  • EPS
  • EBF 1.58
  • ALLO N/A
  • Revenue
  • EBF $399,351,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • EBF N/A
  • ALLO N/A
  • Revenue Next Year
  • EBF N/A
  • ALLO N/A
  • P/E Ratio
  • EBF $13.10
  • ALLO N/A
  • Revenue Growth
  • EBF N/A
  • ALLO 26.47
  • 52 Week Low
  • EBF $18.88
  • ALLO $1.78
  • 52 Week High
  • EBF $25.75
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • EBF 53.89
  • ALLO 39.45
  • Support Level
  • EBF $19.76
  • ALLO $1.78
  • Resistance Level
  • EBF $20.83
  • ALLO $1.91
  • Average True Range (ATR)
  • EBF 0.37
  • ALLO 0.16
  • MACD
  • EBF 0.05
  • ALLO -0.02
  • Stochastic Oscillator
  • EBF 80.26
  • ALLO 13.71

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: